AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,130 | -60.5% | 2,700 | -54.2% | 0.00% | – |
| Q3 2022 | $13,000 | -23.5% | 5,900 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -29.2% | 5,900 | +1.7% | 0.00% | – |
| Q1 2022 | $24,000 | +20.0% | 5,800 | +52.6% | 0.00% | – |
| Q4 2021 | $20,000 | +42.9% | 3,800 | +81.0% | 0.00% | – |
| Q3 2021 | $14,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
| Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
| Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
| SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
| Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
| Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
| Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
| MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
| Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |